CLINICAL_TRIALS
trial_result
· 2016-08-29
Clinical Trial Update: Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation [Phase 2]
Summary
Phase 2 trial evaluating prevention of T-cell co-stimulation for resistant hypertension was terminated; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Vanderbilt University Medical Center | Conditions: Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2016-08-29